INVENTIVA (EPA:IVA) | WebDisclosure

BRIEF

published on 07/23/2024 at 10:56, 9 months 8 days ago

UBS Group exceeds the threshold of 5% of Inventiva's capital

Voting Rights Acquisition Of Shares Crossing Threshold Inventive UBS Group
PRESS RELEASE

published on 07/23/2024 at 10:51, 9 months 8 days ago

Franchissement de seuil
Déclaration de franchissement de seuil par UBS Group AG pour INVENTIVA avec 5,10% du capital et 4,08% des droits de vote, résultant d'une acquisition d'actions hors marché

Franchissement De Seuil Acquisition D'actions Inventiva UBS Group AG Hors Marché
BRIEF

published on 07/18/2024 at 08:35, 9 months 14 days ago

Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros

Biopharmaceutique Inventiva Lanifibranor MASH/NASH Certificats De Royalties
BRIEF

published on 07/18/2024 at 08:35, 9 months 14 days ago

Inventiva announces the issuance of royalty certificates for an amount of 20.1 million euros

Biopharmaceutical Inventive Lanifibranor MASH/NASH Royalty Certificates
PRESS RELEASE

published on 07/18/2024 at 08:30, 9 months 14 days ago

Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros
Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros, souscrits par Samsara BioCapital et des actionnaires existants pour financer le développement du lanifibranor

Développement Inventiva Lanifibranor Certificats De Royalties Samsara BioCapital
PRESS RELEASE

published on 07/18/2024 at 08:30, 9 months 14 days ago

Inventiva announces a €20.1 million issuance of royalty certificates
Inventiva announces a €20.1 million issuance of royalty certificates to fund lanifibranor development, extending cash runway. Key shareholders involved in the transaction

Strategic Options Inventiva Lanifibranor Royalty Certificates Cash Runway
BRIEF

published on 07/05/2024 at 22:05, 9 months 26 days ago

Inventiva : mise à jour sur le programme clinique NATiV3 et état financier

Financement Essai Clinique Inventiva NASH Lanifibranor
BRIEF

published on 07/05/2024 at 22:05, 9 months 26 days ago

Inventiva: update on the NATiV3 clinical program and financial statement

Funding Clinical Test Inventive NASH Lanifibranor
PRESS RELEASE

published on 07/05/2024 at 22:00, 9 months 26 days ago

Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr
Inventiva fait le point sur son programme clinique NATiV3 pour la MASH/NASH et sa situation financière. Recrutement en cours, résultats attendus en 2026

Inventiva NATiV3 NASH MASH Lanifibranor
PRESS RELEASE

published on 07/05/2024 at 22:00, 9 months 26 days ago

Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
Inventiva updates on its clinical program evaluating lanifibranor for MASH/NASH, with positive recruitment and financial outlook. New patents strengthen the company's position

Financial Position Clinical Program Inventiva Lanifibranor MASH/NASH

Published on 05/01/2025 at 08:00, 1 hour 7 minutes ago

Formation Metals Announces Appointment of Adrian Smith to Advisory Committee
Published on 05/01/2025 at 06:40, 2 hours 27 minutes ago

Cerrado Gold Announces Q4 And Annual 2024 Financial Results
Published on 05/01/2025 at 05:25, 3 hours 42 minutes ago

GLG Life Tech Corporation Reports 2024 Annual & Fourth Quarter Financial Results
Published on 05/01/2025 at 05:00, 4 hours 7 minutes ago

Alphinat Announces a Profit of $51,824 for Fiscal Year Ended August 31, 2024
Published on 05/01/2025 at 04:25, 4 hours 42 minutes ago

Alphinat Announces a Profit of $84,870 for Fiscal Year Ended August 31, 2023

View all ACCESSWIRE

Published on 05/01/2025 at 08:30, 37 minutes ago

Travis Perkins Plc: sale of Staircraft business
Published on 05/01/2025 at 08:00, 1 hour 7 minutes ago

Ørsted divests 24.5% stake in West of Duddon Sands Offshore Wind Farm to funds managed by Schroders Greencoat
Published on 05/01/2025 at 08:00, 1 hour 7 minutes ago

Transaction in Own Shares
Published on 05/01/2025 at 08:00, 1 hour 7 minutes ago

Walls & Futures REIT PLC: Holding in the Company
Published on 05/01/2025 at 08:00, 1 hour 7 minutes ago

Cairn Homes Plc: Total Voting Rights

View all EQS

Published on 04/30/2025 at 20:31, 12 hours 36 minutes ago

COMMUNIQUE DE PRESSE - RESULTATS 2024
Published on 04/30/2025 at 19:14, 13 hours 52 minutes ago

Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 13 hours 52 minutes ago

Solocal - Press Release - Filing of 2024 URD
Published on 04/30/2025 at 19:14, 13 hours 52 minutes ago

Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 14 hours 11 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025

View all LES ECHOS COMFI WIRE

News